An ex vivo screening using mouse brain mitochondria identified seco-cycline D as an inhibitor of mitochondrial permeability transition pore
Biochemical and Biophysical Research Communications · 2024-01 · 691 · 149253
DOI: 10.1016/j.bbrc.2023.149253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024-01. Verfasst von Mie Kubota-Sakashita und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine, Bunkyo, Tokyo, 113-8421, Japan; Drug Discovery Seed…. Hauptthemen laut MEDLINE: Mitochondrial Permeability Transition Pore, Mitochondrial Membrane Transport Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, RIKEN, Centre for Studies in Religion and Society, University of Victoria.
Abstract (Originalsprache)
Mitochondrial dysfunction is implicated in neuropsychiatric disorders. Inhibition of mitochondrial permeability transition pore (mPTP) and thereby enhancement of mitochondrial Ca2+ retention capacity (CRC) is a promising treatment strategy. Here, we screened 1718 compounds to search for drug candidates inhibiting mPTP by measuring their effects on CRC in mitochondria isolated from mouse brains. We identified seco-cycline D (SCD) as an active compound. SCD and its derivative were more potent than a known mPTP inhibitor, cyclosporine A (CsA). The mechanism of action of SCD was suggested likely to be different from CsA that acts on cyclophilin D. Repeated administration of SCD decreased ischemic area in a middle cerebral artery occlusion model in mice. These results suggest that SCD is a useful probe to explore mPTP function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine, Bunkyo, Tokyo, 113-8421, Japan; Drug Discovery Seed Compounds Exploratory Unit, RIKEN Center for Sustainable Resource Sci…
- Drug Discovery Chemistry Platform Unit, RIKEN Center for Sustainable Resource Science, Wako, Saitama, 351-0198, Japan.
- Molecular Structure Characterization Unit, RIKEN Center for Sustainable Resource Science, Wako, Saitama, 351-0198, Japan.
- Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine, Bunkyo, Tokyo, 113-8421, Japan. Electronic address: tadafumi.kato@juntendo.ac.jp.
Förderung
- Japan Agency for Medical Research and Development
- RIKEN
- Centre for Studies in Religion and Society, University of Victoria
Zitieren
APA
Kubota-Sakashita, M., Kawakami, H., Kikuzato, K., Shirai, F., Nakamura, T., & Kato, T. (2024). An ex vivo screening using mouse brain mitochondria identified seco-cycline D as an inhibitor of mitochondrial permeability transition pore. Biochemical and Biophysical Research Communications, 691, 149253. https://doi.org/10.1016/j.bbrc.2023.149253
Vancouver
Kubota-Sakashita M, Kawakami H, Kikuzato K, Shirai F, Nakamura T, Kato T. An ex vivo screening using mouse brain mitochondria identified seco-cycline D as an inhibitor of mitochondrial permeability transition pore. Biochemical and Biophysical Research Communications. 2024;691:149253. doi:10.1016/j.bbrc.2023.149253
BibTeX
@article{KubotaSakashita2024,
author = {Kubota-Sakashita, Mie and Kawakami, Hirochika and Kikuzato, Ko and Shirai, Fumiyuki and Nakamura, Takemichi and Kato, Tadafumi},
title = {An ex vivo screening using mouse brain mitochondria identified seco-cycline D as an inhibitor of mitochondrial permeability transition pore},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
volume = {691},
pages = {149253},
doi = {10.1016/j.bbrc.2023.149253}
}
EUVIMED